INOVIO PHARMACEUTICALS, INC.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $6.1M | $9.1M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $13.3M | $9.4M |
| SG&A Expense | $12.1M | $13.7M |
| Operating Income | $-19.2M | $-14.0M |
| Operating Margin | -312.8% | -153.0% |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | $71.0K | — |
| Net Income | $-17.6M | $-24.4M |
| Net Margin | -286.6% | -267.7% |
| EPS (Basic) | $-0.17 | $-0.33 |
| EPS (Diluted) | $-0.17 | $-0.33 |
| Shares Outstanding (Basic) | 105.0M | — |
| Shares Outstanding (Diluted) | 105.0M | — |
| Dividends Per Share | — | — |